171 related articles for article (PubMed ID: 16317434)
1. No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix.
Kabuubi P; Loncaster JA; Davidson SE; Hunter RD; Kobylecki C; Stratford IJ; West CM
Br J Cancer; 2006 Jan; 94(1):115-20. PubMed ID: 16317434
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer.
Kodama J; Yoshinouchi M; Seki N; Hongo A; Miyagi Y; Kudo T
Int J Oncol; 1999 Jul; 15(1):149-54. PubMed ID: 10375608
[TBL] [Abstract][Full Text] [Related]
3. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer.
Nagaoka H; Iino Y; Takei H; Morishita Y
Int J Oncol; 1998 Sep; 13(3):449-54. PubMed ID: 9683777
[TBL] [Abstract][Full Text] [Related]
6. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer.
Tanaka T; Yoshiki T; Arai Y; Higuchi K; Kageyama S; Ogawa Y; Isono T; Okada Y
Jpn J Cancer Res; 1999 Dec; 90(12):1344-50. PubMed ID: 10665652
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
Kitazono M; Takebayashi Y; Ishitsuka K; Takao S; Tani A; Furukawa T; Miyadera K; Yamada Y; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1998 Dec; 253(3):797-803. PubMed ID: 9918807
[TBL] [Abstract][Full Text] [Related]
8. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW
Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662
[TBL] [Abstract][Full Text] [Related]
9. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
Tsujitani S; Saito H; Maeta Y; Yamaguchi K; Tatebe S; Kondo A; Kaibara N
Anticancer Res; 2004; 24(3b):1853-9. PubMed ID: 15274366
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived endothelial cell growth factor as a prognostic factor for radiotherapy outcome in patients with adenocarcinoma of the uterine cervix.
Ryu SY; Oka K; Tsujii H; Suzuki Y; Nakano T
Gynecol Oncol; 2003 Jun; 89(3):414-9. PubMed ID: 12798704
[TBL] [Abstract][Full Text] [Related]
11. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
[TBL] [Abstract][Full Text] [Related]
12. Expression of thymidine phosphorylase in human cervical cancer.
Hata K; Takebayashi Y; Iida K; Fujiwaki R; Fukumoto M; Miyazaki K
Anticancer Res; 1999; 19(1B):709-16. PubMed ID: 10216481
[TBL] [Abstract][Full Text] [Related]
13. Tumor vascularity: a histological measure of angiogenesis and hypoxia.
West CM; Cooper RA; Loncaster JA; Wilks DP; Bromley M
Cancer Res; 2001 Apr; 61(7):2907-10. PubMed ID: 11306466
[TBL] [Abstract][Full Text] [Related]
14. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
15. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
Giatromanolaki A; Sivridis E; Kouskoukis C; Gatter KC; Harris AL; Koukourakis MI
Melanoma Res; 2003 Oct; 13(5):493-501. PubMed ID: 14512791
[TBL] [Abstract][Full Text] [Related]
17. Expression of thymidine phosphorylase and VEGF in esophageal squamous cell carcinoma.
Nomiya T; Nemoto K; Nakata E; Takai Y; Yamada S
Oncol Rep; 2006 Jun; 15(6):1497-501. PubMed ID: 16685385
[TBL] [Abstract][Full Text] [Related]
18. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer.
Kimura Y; Morohashi S; Yoshizawa T; Suzuki T; Morohashi H; Sakamoto Y; Koyama M; Murata A; Kijima H; Hakamada K
Mol Med Rep; 2016 Feb; 13(2):1551-7. PubMed ID: 26676225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
